Deutsche Bank
SKBI

Deutsche Bank’s SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) SKBI Stock Holding History

Deutsche Bank’s Portfolio SKBI Stock Details SKBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-908
Closed -$3K – 5599
2015
Q1 		$3K Sell
908
-1,291
-59% -$5.47K ﹤0.01% 4969
2014
Q4 		$9K Buy
+2,199
New +$9.49K ﹤0.01% 5756

Other funds holding SKBI

BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
CAM
ClariVest Asset Management San Diego, California $980M AUM 60.89% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
SIM
Spark Investment Management New York $41.6M AUM 80.97% 1-Year Est. Return
EGA
Eagle Global Advisors Houston, Texas $2.78B AUM 26.09% 1-Year Est. Return

Deutsche Bank's SKBI Position: Q2 2015 in Review

Deutsche Bank sold out of SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) (SKBI) in Q2 2015, closing a stake of 908 shares — an estimated $3K sold.

Deutsche Bank first reported a position in SKBI in Q4 2014 and held it in 2 quarters. The position peaked at $9K in Q4 2014. 15 funds tracked by Wall St. Rank hold SKBI as of Q2 2015.

  • Deutsche Bank reported no remaining SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) position as of Q2 2015 after selling out during the quarter.
  • Deutsche Bank sold 908 SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) shares in Q2 2015, an estimated $3K.
  • Deutsche Bank first reported a position in SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) in Q4 2014 and held it in 2 quarters.
  • Deutsche Bank's SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) position peaked at $9K in Q4 2014.
  • 15 funds tracked by Wall St. Rank held SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) as of Q2 2015.

Based on Deutsche Bank's 13F filing for Q2 2015, filed 12 Aug 2015.